Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
English
|
Myasthenia gravis and other myoneural disorders |
French
|
Myasthénie et autres affections neuro-musculaires |
| Level | Code | Title | |
|---|---|---|---|
| 1 | VI | Diseases of the nervous system | |
| 2 | G70-G73 | Diseases of myoneural junction and muscle | |
| 3 | G70 | Myasthenia gravis and other myoneural disorders |
| Code | Title | |
|---|---|---|
| G70.0 | Myasthenia gravis | |
| G70.1 | Toxic myoneural disorders | |
| G70.2 | Congenital and developmental myasthenia | |
| G70.8 | Other specified myoneural disorders | |
| G70.9 | Myoneural disorder, unspecified |
| Active Ingredient | Description | |
|---|---|---|
| Distigmine |
|
|
| Neostigmine |
Neostigmine inhibits cholinesterase activity and prolongs and intensifies the muscarinic and nicotinic effects of acetylcholine. The anticholinesterase actions of neostigmine are reversible. It is used mainly for its action on skeletal muscle and less frequently to increase the activity of smooth muscle. |
|
| Pyridostigmine |
Pyridostigmine is an antagonist to cholinesterase, the enzyme which normally destroys acetylcholine. The action of pyridostigmine can briefly be described, therefore, as the potentiation of naturally occurring acetylcholine. |
